Log in or Sign up for Free to view tailored content for your specialty!
Bone Marrow Transplantation News
ASCO: Even light alcohol use increases risk for cancer
Alcohol use — whether light, moderate or heavy — increases cancer risk, and public health measures are needed to reduce high-risk alcohol consumption, according to an ASCO statement.
Healio.com to provide live coverage of Chemotherapy Foundation Symposium
HemOnc Today and Healio.com/HemOnc will provide live coverage of the Chemotherapy Foundation Symposium, which will be held Nov. 8-10 in New York.
Log in or Sign up for Free to view tailored content for your specialty!
Commission issues roadmap to deliver cancer moonshot initiatives
Nearly 2 years after former Vice President Joe Biden unveiled the cancer moonshot initiative, The Lancet Oncology Commission has detailed a roadmap to deliver on the recommendations of the moonshot’s blue ribbon panel.
Three clinicians elected to ASH executive committee
ASH today announced the election of three new members to its executive committee.
AAP stresses value of public vs. private cord blood banks
A joint policy statement released by the AAP Sections on Hematology/Oncology and Allergy and Immunology emphasizes the importance of donating cord blood to public banks for later use in hematopoietic stem cell transplantation to treat children with malignancies, blood disorders, immune deficiencies and metabolic disorders.
Minimal residual disease shows significant prognostic value for multiple myeloma
Minimal residual disease detected by next-generation sequencing following autologous hematopoietic stem cell transplantation had significant prognostic value among patients with multiple myeloma, according to results of a study published in Annals of Oncology.
AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized the importance of robust medical research funding.
VIDEO: Letermovir CMV prophylaxis offers survival benefit in hematopoietic cell transplant patients
SAN DIEGO — Francisco Marty, MD, associate professor of medicine at Harvard Medical School and attending physician at Dana-Farber Cancer Institute and Brigham and Women’s Hospital, reviews the efficacy of letermovir as prophylaxis for cytomegalovirus in high-risk hematopoietic cell transplant patients.
NIH collaboration aims to identify, validate immunotherapy biomarkers
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration.
Pretransplant vitamin D deficiency may heighten relapse risk in myeloid malignancies
A deficiency in vitamin D prior to allogeneic hematopoietic stem cell transplantation increased risk for relapse among patients with myeloid malignancies, according to a retrospective study published in Journal of Clinical Oncology.
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read
-
Headline News
CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots
November 18, 20241 min read -
Headline News
Obesity drugs could help lower alcohol intake
November 18, 20243 min read -
Headline News
Pediatric asthma ‘potential source of cognitive difficulty’
November 18, 20242 min read